0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Disease Testing Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Othe-4U222
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Infectious Disease Testing Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Infectious Disease Testing Market Insights, Forecast to 2029

Code: QYRE-Othe-4U222
Report
August 2023
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Infectious Disease Testing Market Size

The global Infectious Disease Testing market is projected to grow from US$ 17160 million in 2023 to US$ 21090 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.

Infectious Disease Testing Market

Infectious Disease Testing Market

In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
Market Analysis and Insights: Global Infectious Disease Testing Market
Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.
Report Includes
This report presents an overview of global market for Infectious Disease Testing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Infectious Disease Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Infectious Disease Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Infectious Disease Testing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Infectious Disease Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by technology and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Infectious Disease Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Diagnostics, Abbott, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq and BD, etc.

Scope of Infectious Disease Testing Market Report

Report Metric Details
Report Name Infectious Disease Testing Market
Accounted market size in 2023 US$ 17160 million
Forecasted market size in 2029 US$ 21090 million
CAGR 3.5
Base Year 2023
Forecasted years 2023 - 2029
Segment by Technology
  • Immunodiagnostics
  • Clinical Microbiology
  • PCR
  • INAAT
  • DNA Sequencing & NGS
  • DNA Microarrays
  • Other
Segment by Application
  • Hospitals/Clinical Laboratories
  • Reference Laboratories
  • Academic/Research Institutes
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Diagnostics, Abbott, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, Life Technologies, Maxim Biomedical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Infectious Disease Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Infectious Disease Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by technology, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by technology, by application and by country, revenue for each segment.
  • Chapter 7: Europe by technology, by application and by country, revenue for each segment.
  • Chapter 8: China by technology and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by technology, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by technology, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Infectious Disease Testing revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Infectious Disease Testing Market growing?

Ans: The Infectious Disease Testing Market witnessing a CAGR of 3.5 during the forecast period 2023-2029.

What is the Infectious Disease Testing Market size in 2029?

Ans: The global Infectious Disease Testing market is projected to grow from US$ 17160 million in 2023 to US$ 21090 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.

Who are the main players in the Infectious Disease Testing Market report?

Ans: The main players in the Infectious Disease Testing Market are Abbott Diagnostics, Abbott, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, Life Technologies, Maxim Biomedical

What are the Application segmentation covered in the Infectious Disease Testing Market report?

Ans: The Applications covered in the Infectious Disease Testing Market report are Hospitals/Clinical Laboratories, Reference Laboratories, Academic/Research Institutes, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Technology
1.2.1 Global Infectious Disease Testing Market Size Growth Rate by Technology, 2018 VS 2022 VS 2029
1.2.2 Immunodiagnostics
1.2.3 Clinical Microbiology
1.2.4 PCR
1.2.5 INAAT
1.2.6 DNA Sequencing & NGS
1.2.7 DNA Microarrays
1.2.8 Other
1.3 Market by Application
1.3.1 Global Infectious Disease Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals/Clinical Laboratories
1.3.3 Reference Laboratories
1.3.4 Academic/Research Institutes
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Testing Market Perspective (2018-2029)
2.2 Global Infectious Disease Testing Growth Trends by Region
2.2.1 Infectious Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Infectious Disease Testing Historic Market Size by Region (2018-2023)
2.2.3 Infectious Disease Testing Forecasted Market Size by Region (2024-2029)
2.3 Infectious Disease Testing Market Dynamics
2.3.1 Infectious Disease Testing Industry Trends
2.3.2 Infectious Disease Testing Market Drivers
2.3.3 Infectious Disease Testing Market Challenges
2.3.4 Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Infectious Disease Testing by Players
3.1.1 Global Infectious Disease Testing Revenue by Players (2018-2023)
3.1.2 Global Infectious Disease Testing Revenue Market Share by Players (2018-2023)
3.2 Global Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Infectious Disease Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Testing Revenue in 2022
3.5 Global Key Players of Infectious Disease Testing Head office and Area Served
3.6 Global Key Players of Infectious Disease Testing, Product and Application
3.7 Global Key Players of Infectious Disease Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Testing Breakdown Data by Technology
4.1 Global Infectious Disease Testing Historic Market Size by Technology (2018-2023)
4.2 Global Infectious Disease Testing Forecasted Market Size by Technology (2024-2029)
5 Infectious Disease Testing Breakdown Data by Application
5.1 Global Infectious Disease Testing Historic Market Size by Application (2018-2023)
5.2 Global Infectious Disease Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Infectious Disease Testing Market Size (2018-2029)
6.2 North America Infectious Disease Testing Market Size by Technology
6.2.1 North America Infectious Disease Testing Market Size by Technology (2018-2023)
6.2.2 North America Infectious Disease Testing Market Size by Technology (2024-2029)
6.2.3 North America Infectious Disease Testing Market Share by Technology (2018-2029)
6.3 North America Infectious Disease Testing Market Size by Application
6.3.1 North America Infectious Disease Testing Market Size by Application (2018-2023)
6.3.2 North America Infectious Disease Testing Market Size by Application (2024-2029)
6.3.3 North America Infectious Disease Testing Market Share by Application (2018-2029)
6.4 North America Infectious Disease Testing Market Size by Country
6.4.1 North America Infectious Disease Testing Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Infectious Disease Testing Market Size by Country (2018-2023)
6.4.3 North America Infectious Disease Testing Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Infectious Disease Testing Market Size (2018-2029)
7.2 Europe Infectious Disease Testing Market Size by Technology
7.2.1 Europe Infectious Disease Testing Market Size by Technology (2018-2023)
7.2.2 Europe Infectious Disease Testing Market Size by Technology (2024-2029)
7.2.3 Europe Infectious Disease Testing Market Share by Technology (2018-2029)
7.3 Europe Infectious Disease Testing Market Size by Application
7.3.1 Europe Infectious Disease Testing Market Size by Application (2018-2023)
7.3.2 Europe Infectious Disease Testing Market Size by Application (2024-2029)
7.3.3 Europe Infectious Disease Testing Market Share by Application (2018-2029)
7.4 Europe Infectious Disease Testing Market Size by Country
7.4.1 Europe Infectious Disease Testing Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Infectious Disease Testing Market Size by Country (2018-2023)
7.4.3 Europe Infectious Disease Testing Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Infectious Disease Testing Market Size (2018-2029)
8.2 China Infectious Disease Testing Market Size by Technology
8.2.1 China Infectious Disease Testing Market Size by Technology (2018-2023)
8.2.2 China Infectious Disease Testing Market Size by Technology (2024-2029)
8.2.3 China Infectious Disease Testing Market Share by Technology (2018-2029)
8.3 China Infectious Disease Testing Market Size by Application
8.3.1 China Infectious Disease Testing Market Size by Application (2018-2023)
8.3.2 China Infectious Disease Testing Market Size by Application (2024-2029)
8.3.3 China Infectious Disease Testing Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Infectious Disease Testing Market Size (2018-2029)
9.2 Asia Infectious Disease Testing Market Size by Technology
9.2.1 Asia Infectious Disease Testing Market Size by Technology (2018-2023)
9.2.2 Asia Infectious Disease Testing Market Size by Technology (2024-2029)
9.2.3 Asia Infectious Disease Testing Market Share by Technology (2018-2029)
9.3 Asia Infectious Disease Testing Market Size by Application
9.3.1 Asia Infectious Disease Testing Market Size by Application (2018-2023)
9.3.2 Asia Infectious Disease Testing Market Size by Application (2024-2029)
9.3.3 Asia Infectious Disease Testing Market Share by Application (2018-2029)
9.4 Asia Infectious Disease Testing Market Size by Region
9.4.1 Asia Infectious Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Infectious Disease Testing Market Size by Region (2018-2023)
9.4.3 Asia Infectious Disease Testing Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Infectious Disease Testing Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Technology
10.2.1 Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Technology (2018-2023)
10.2.2 Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Technology (2024-2029)
10.2.3 Middle East, Africa, and Latin America Infectious Disease Testing Market Share by Technology (2018-2029)
10.3 Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Infectious Disease Testing Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Infectious Disease Testing Introduction
11.1.4 Abbott Diagnostics Revenue in Infectious Disease Testing Business (2018-2023)
11.1.5 Abbott Diagnostics Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Infectious Disease Testing Introduction
11.2.4 Abbott Revenue in Infectious Disease Testing Business (2018-2023)
11.2.5 Abbott Recent Developments
11.3 Beckman Coulter Diagnostics
11.3.1 Beckman Coulter Diagnostics Company Details
11.3.2 Beckman Coulter Diagnostics Business Overview
11.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Introduction
11.3.4 Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2018-2023)
11.3.5 Beckman Coulter Diagnostics Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Infectious Disease Testing Introduction
11.4.4 Roche Revenue in Infectious Disease Testing Business (2018-2023)
11.4.5 Roche Recent Developments
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Details
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Infectious Disease Testing Introduction
11.5.4 Siemens Healthcare Revenue in Infectious Disease Testing Business (2018-2023)
11.5.5 Siemens Healthcare Recent Developments
11.6 Abaxis
11.6.1 Abaxis Company Details
11.6.2 Abaxis Business Overview
11.6.3 Abaxis Infectious Disease Testing Introduction
11.6.4 Abaxis Revenue in Infectious Disease Testing Business (2018-2023)
11.6.5 Abaxis Recent Developments
11.7 Acon Laboratories
11.7.1 Acon Laboratories Company Details
11.7.2 Acon Laboratories Business Overview
11.7.3 Acon Laboratories Infectious Disease Testing Introduction
11.7.4 Acon Laboratories Revenue in Infectious Disease Testing Business (2018-2023)
11.7.5 Acon Laboratories Recent Developments
11.8 Avioq
11.8.1 Avioq Company Details
11.8.2 Avioq Business Overview
11.8.3 Avioq Infectious Disease Testing Introduction
11.8.4 Avioq Revenue in Infectious Disease Testing Business (2018-2023)
11.8.5 Avioq Recent Developments
11.9 BD
11.9.1 BD Company Details
11.9.2 BD Business Overview
11.9.3 BD Infectious Disease Testing Introduction
11.9.4 BD Revenue in Infectious Disease Testing Business (2018-2023)
11.9.5 BD Recent Developments
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Infectious Disease Testing Introduction
11.10.4 Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2018-2023)
11.10.5 Bio-Rad Laboratories Recent Developments
11.11 Cavidi
11.11.1 Cavidi Company Details
11.11.2 Cavidi Business Overview
11.11.3 Cavidi Infectious Disease Testing Introduction
11.11.4 Cavidi Revenue in Infectious Disease Testing Business (2018-2023)
11.11.5 Cavidi Recent Developments
11.12 Cepheid
11.12.1 Cepheid Company Details
11.12.2 Cepheid Business Overview
11.12.3 Cepheid Infectious Disease Testing Introduction
11.12.4 Cepheid Revenue in Infectious Disease Testing Business (2018-2023)
11.12.5 Cepheid Recent Developments
11.13 Chembio Diagnostic Systems
11.13.1 Chembio Diagnostic Systems Company Details
11.13.2 Chembio Diagnostic Systems Business Overview
11.13.3 Chembio Diagnostic Systems Infectious Disease Testing Introduction
11.13.4 Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2018-2023)
11.13.5 Chembio Diagnostic Systems Recent Developments
11.14 Clarity Diagnostics
11.14.1 Clarity Diagnostics Company Details
11.14.2 Clarity Diagnostics Business Overview
11.14.3 Clarity Diagnostics Infectious Disease Testing Introduction
11.14.4 Clarity Diagnostics Revenue in Infectious Disease Testing Business (2018-2023)
11.14.5 Clarity Diagnostics Recent Developments
11.15 EMD Millipore
11.15.1 EMD Millipore Company Details
11.15.2 EMD Millipore Business Overview
11.15.3 EMD Millipore Infectious Disease Testing Introduction
11.15.4 EMD Millipore Revenue in Infectious Disease Testing Business (2018-2023)
11.15.5 EMD Millipore Recent Developments
11.16 Epitope Diagnostic
11.16.1 Epitope Diagnostic Company Details
11.16.2 Epitope Diagnostic Business Overview
11.16.3 Epitope Diagnostic Infectious Disease Testing Introduction
11.16.4 Epitope Diagnostic Revenue in Infectious Disease Testing Business (2018-2023)
11.16.5 Epitope Diagnostic Recent Developments
11.17 Gold Standard Diagnostics
11.17.1 Gold Standard Diagnostics Company Details
11.17.2 Gold Standard Diagnostics Business Overview
11.17.3 Gold Standard Diagnostics Infectious Disease Testing Introduction
11.17.4 Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2018-2023)
11.17.5 Gold Standard Diagnostics Recent Developments
11.18 Hologic
11.18.1 Hologic Company Details
11.18.2 Hologic Business Overview
11.18.3 Hologic Infectious Disease Testing Introduction
11.18.4 Hologic Revenue in Infectious Disease Testing Business (2018-2023)
11.18.5 Hologic Recent Developments
11.19 Immunetics
11.19.1 Immunetics Company Details
11.19.2 Immunetics Business Overview
11.19.3 Immunetics Infectious Disease Testing Introduction
11.19.4 Immunetics Revenue in Infectious Disease Testing Business (2018-2023)
11.19.5 Immunetics Recent Developments
11.20 InBios International
11.20.1 InBios International Company Details
11.20.2 InBios International Business Overview
11.20.3 InBios International Infectious Disease Testing Introduction
11.20.4 InBios International Revenue in Infectious Disease Testing Business (2018-2023)
11.20.5 InBios International Recent Developments
11.21 Life Technologies
11.21.1 Life Technologies Company Details
11.21.2 Life Technologies Business Overview
11.21.3 Life Technologies Infectious Disease Testing Introduction
11.21.4 Life Technologies Revenue in Infectious Disease Testing Business (2018-2023)
11.21.5 Life Technologies Recent Developments
11.22 Maxim Biomedical
11.22.1 Maxim Biomedical Company Details
11.22.2 Maxim Biomedical Business Overview
11.22.3 Maxim Biomedical Infectious Disease Testing Introduction
11.22.4 Maxim Biomedical Revenue in Infectious Disease Testing Business (2018-2023)
11.22.5 Maxim Biomedical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Infectious Disease Testing Market Size Growth Rate by Technology (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Immunodiagnostics
    Table 3. Key Players of Clinical Microbiology
    Table 4. Key Players of PCR
    Table 5. Key Players of INAAT
    Table 6. Key Players of DNA Sequencing & NGS
    Table 7. Key Players of DNA Microarrays
    Table 8. Key Players of Other
    Table 9. Global Infectious Disease Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 10. Global Infectious Disease Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 11. Global Infectious Disease Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 12. Global Infectious Disease Testing Market Share by Region (2018-2023)
    Table 13. Global Infectious Disease Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 14. Global Infectious Disease Testing Market Share by Region (2024-2029)
    Table 15. Infectious Disease Testing Market Trends
    Table 16. Infectious Disease Testing Market Drivers
    Table 17. Infectious Disease Testing Market Challenges
    Table 18. Infectious Disease Testing Market Restraints
    Table 19. Global Infectious Disease Testing Revenue by Players (2018-2023) & (US$ Million)
    Table 20. Global Infectious Disease Testing Revenue Share by Players (2018-2023)
    Table 21. Global Top Infectious Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Testing as of 2022)
    Table 22. Global Infectious Disease Testing Industry Ranking 2021 VS 2022 VS 2023
    Table 23. Global 5 Largest Players Market Share by Infectious Disease Testing Revenue (CR5 and HHI) & (2018-2023)
    Table 24. Global Key Players of Infectious Disease Testing, Headquarters and Area Served
    Table 25. Global Key Players of Infectious Disease Testing, Product and Application
    Table 26. Global Key Players of Infectious Disease Testing, Product and Application
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Infectious Disease Testing Market Size by Technology (2018-2023) & (US$ Million)
    Table 29. Global Infectious Disease Testing Revenue Market Share by Technology (2018-2023)
    Table 30. Global Infectious Disease Testing Forecasted Market Size by Technology (2024-2029) & (US$ Million)
    Table 31. Global Infectious Disease Testing Revenue Market Share by Technology (2024-2029)
    Table 32. Global Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 33. Global Infectious Disease Testing Revenue Share by Application (2018-2023)
    Table 34. Global Infectious Disease Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 35. Global Infectious Disease Testing Revenue Share by Application (2024-2029)
    Table 36. North America Infectious Disease Testing Market Size by Technology (2018-2023) & (US$ Million)
    Table 37. North America Infectious Disease Testing Market Size by Technology (2024-2029) & (US$ Million)
    Table 38. North America Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 39. North America Infectious Disease Testing Market Size by Application (2024-2029) & (US$ Million)
    Table 40. North America Infectious Disease Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. North America Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 42. North America Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Europe Infectious Disease Testing Market Size by Technology (2018-2023) & (US$ Million)
    Table 44. Europe Infectious Disease Testing Market Size by Technology (2024-2029) & (US$ Million)
    Table 45. Europe Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 46. Europe Infectious Disease Testing Market Size by Application (2024-2029) & (US$ Million)
    Table 47. Europe Infectious Disease Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 48. Europe Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 49. Europe Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 50. China Infectious Disease Testing Market Size by Technology (2018-2023) & (US$ Million)
    Table 51. China Infectious Disease Testing Market Size by Technology (2024-2029) & (US$ Million)
    Table 52. China Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 53. China Infectious Disease Testing Market Size by Application (2024-2029) & (US$ Million)
    Table 54. Asia Infectious Disease Testing Market Size by Technology (2018-2023) & (US$ Million)
    Table 55. Asia Infectious Disease Testing Market Size by Technology (2024-2029) & (US$ Million)
    Table 56. Asia Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 57. Asia Infectious Disease Testing Market Size by Application (2024-2029) & (US$ Million)
    Table 58. Asia Infectious Disease Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 59. Asia Infectious Disease Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 60. Asia Infectious Disease Testing Market Size by Region (2024-2029) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Technology (2018-2023) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Technology (2024-2029) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Application (2024-2029) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Infectious Disease Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 66. Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 67. Middle East, Africa, and Latin America Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 68. Abbott Diagnostics Company Details
    Table 69. Abbott Diagnostics Business Overview
    Table 70. Abbott Diagnostics Infectious Disease Testing Product
    Table 71. Abbott Diagnostics Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 72. Abbott Diagnostics Recent Developments
    Table 73. Abbott Company Details
    Table 74. Abbott Business Overview
    Table 75. Abbott Infectious Disease Testing Product
    Table 76. Abbott Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 77. Abbott Recent Developments
    Table 78. Beckman Coulter Diagnostics Company Details
    Table 79. Beckman Coulter Diagnostics Business Overview
    Table 80. Beckman Coulter Diagnostics Infectious Disease Testing Product
    Table 81. Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 82. Beckman Coulter Diagnostics Recent Developments
    Table 83. Roche Company Details
    Table 84. Roche Business Overview
    Table 85. Roche Infectious Disease Testing Product
    Table 86. Roche Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 87. Roche Recent Developments
    Table 88. Siemens Healthcare Company Details
    Table 89. Siemens Healthcare Business Overview
    Table 90. Siemens Healthcare Infectious Disease Testing Product
    Table 91. Siemens Healthcare Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 92. Siemens Healthcare Recent Developments
    Table 93. Abaxis Company Details
    Table 94. Abaxis Business Overview
    Table 95. Abaxis Infectious Disease Testing Product
    Table 96. Abaxis Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 97. Abaxis Recent Developments
    Table 98. Acon Laboratories Company Details
    Table 99. Acon Laboratories Business Overview
    Table 100. Acon Laboratories Infectious Disease Testing Product
    Table 101. Acon Laboratories Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 102. Acon Laboratories Recent Developments
    Table 103. Avioq Company Details
    Table 104. Avioq Business Overview
    Table 105. Avioq Infectious Disease Testing Product
    Table 106. Avioq Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 107. Avioq Recent Developments
    Table 108. BD Company Details
    Table 109. BD Business Overview
    Table 110. BD Infectious Disease Testing Product
    Table 111. BD Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 112. BD Recent Developments
    Table 113. Bio-Rad Laboratories Company Details
    Table 114. Bio-Rad Laboratories Business Overview
    Table 115. Bio-Rad Laboratories Infectious Disease Testing Product
    Table 116. Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 117. Bio-Rad Laboratories Recent Developments
    Table 118. Cavidi Company Details
    Table 119. Cavidi Business Overview
    Table 120. Cavidi Infectious Disease Testing Product
    Table 121. Cavidi Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 122. Cavidi Recent Developments
    Table 123. Cepheid Company Details
    Table 124. Cepheid Business Overview
    Table 125. Cepheid Infectious Disease Testing Product
    Table 126. Cepheid Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 127. Cepheid Recent Developments
    Table 128. Chembio Diagnostic Systems Company Details
    Table 129. Chembio Diagnostic Systems Business Overview
    Table 130. Chembio Diagnostic Systems Infectious Disease Testing Product
    Table 131. Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 132. Chembio Diagnostic Systems Recent Developments
    Table 133. Clarity Diagnostics Company Details
    Table 134. Clarity Diagnostics Business Overview
    Table 135. Clarity Diagnostics Infectious Disease Testing Product
    Table 136. Clarity Diagnostics Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 137. Clarity Diagnostics Recent Developments
    Table 138. EMD Millipore Company Details
    Table 139. EMD Millipore Business Overview
    Table 140. EMD Millipore Infectious Disease Testing Product
    Table 141. EMD Millipore Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 142. EMD Millipore Recent Developments
    Table 143. Epitope Diagnostic Company Details
    Table 144. Epitope Diagnostic Business Overview
    Table 145. Epitope Diagnostic Infectious Disease Testing Product
    Table 146. Epitope Diagnostic Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 147. Epitope Diagnostic Recent Developments
    Table 148. Gold Standard Diagnostics Company Details
    Table 149. Gold Standard Diagnostics Business Overview
    Table 150. Gold Standard Diagnostics Infectious Disease Testing Product
    Table 151. Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 152. Gold Standard Diagnostics Recent Developments
    Table 153. Hologic Company Details
    Table 154. Hologic Business Overview
    Table 155. Hologic Infectious Disease Testing Product
    Table 156. Hologic Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 157. Hologic Recent Developments
    Table 158. Immunetics Company Details
    Table 159. Immunetics Business Overview
    Table 160. Immunetics Infectious Disease Testing Product
    Table 161. Immunetics Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 162. Immunetics Recent Developments
    Table 163. InBios International Company Details
    Table 164. InBios International Business Overview
    Table 165. InBios International Infectious Disease Testing Product
    Table 166. InBios International Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 167. InBios International Recent Developments
    Table 168. Life Technologies Company Details
    Table 169. Life Technologies Business Overview
    Table 170. Life Technologies Infectious Disease Testing Product
    Table 171. Life Technologies Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 172. Life Technologies Recent Developments
    Table 173. Maxim Biomedical Company Details
    Table 174. Maxim Biomedical Business Overview
    Table 175. Maxim Biomedical Infectious Disease Testing Product
    Table 176. Maxim Biomedical Revenue in Infectious Disease Testing Business (2018-2023) & (US$ Million)
    Table 177. Maxim Biomedical Recent Developments
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Infectious Disease Testing Market Size Growth Rate by Technology, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Infectious Disease Testing Market Share by Technology: 2022 VS 2029
    Figure 3. Immunodiagnostics Features
    Figure 4. Clinical Microbiology Features
    Figure 5. PCR Features
    Figure 6. INAAT Features
    Figure 7. DNA Sequencing & NGS Features
    Figure 8. DNA Microarrays Features
    Figure 9. Other Features
    Figure 10. Global Infectious Disease Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 11. Global Infectious Disease Testing Market Share by Application: 2022 VS 2029
    Figure 12. Hospitals/Clinical Laboratories Case Studies
    Figure 13. Reference Laboratories Case Studies
    Figure 14. Academic/Research Institutes Case Studies
    Figure 15. Other Case Studies
    Figure 16. Infectious Disease Testing Report Years Considered
    Figure 17. Global Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 18. Global Infectious Disease Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 19. Global Infectious Disease Testing Market Share by Region: 2022 VS 2029
    Figure 20. Global Infectious Disease Testing Market Share by Players in 2022
    Figure 21. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Testing as of 2022)
    Figure 22. The Top 10 and 5 Players Market Share by Infectious Disease Testing Revenue in 2022
    Figure 23. North America Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. North America Infectious Disease Testing Market Share by Technology (2018-2029)
    Figure 25. North America Infectious Disease Testing Market Share by Application (2018-2029)
    Figure 26. North America Infectious Disease Testing Market Share by Country (2018-2029)
    Figure 27. United States Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Canada Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Europe Infectious Disease Testing Market Size YoY (2018-2029) & (US$ Million)
    Figure 30. Europe Infectious Disease Testing Market Share by Technology (2018-2029)
    Figure 31. Europe Infectious Disease Testing Market Share by Application (2018-2029)
    Figure 32. Europe Infectious Disease Testing Market Share by Country (2018-2029)
    Figure 33. Germany Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. France Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. U.K. Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Italy Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Russia Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Nordic Countries Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. China Infectious Disease Testing Market Size YoY (2018-2029) & (US$ Million)
    Figure 40. China Infectious Disease Testing Market Share by Technology (2018-2029)
    Figure 41. China Infectious Disease Testing Market Share by Application (2018-2029)
    Figure 42. Asia Infectious Disease Testing Market Size YoY (2018-2029) & (US$ Million)
    Figure 43. Asia Infectious Disease Testing Market Share by Technology (2018-2029)
    Figure 44. Asia Infectious Disease Testing Market Share by Application (2018-2029)
    Figure 45. Asia Infectious Disease Testing Market Share by Region (2018-2029)
    Figure 46. Japan Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. South Korea Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. China Taiwan Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Southeast Asia Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 50. India Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 51. Australia Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Infectious Disease Testing Market Size YoY (2018-2029) & (US$ Million)
    Figure 53. Middle East, Africa, and Latin America Infectious Disease Testing Market Share by Technology (2018-2029)
    Figure 54. Middle East, Africa, and Latin America Infectious Disease Testing Market Share by Application (2018-2029)
    Figure 55. Middle East, Africa, and Latin America Infectious Disease Testing Market Share by Country (2018-2029)
    Figure 56. Brazil Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. Mexico Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 58. Turkey Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 59. Saudi Arabia Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 60. Israel Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 61. GCC Countries Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 62. Abbott Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 63. Abbott Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 64. Beckman Coulter Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 65. Roche Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 66. Siemens Healthcare Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 67. Abaxis Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 68. Acon Laboratories Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 69. Avioq Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 70. BD Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 71. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 72. Cavidi Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 73. Cepheid Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 74. Chembio Diagnostic Systems Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 75. Clarity Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 76. EMD Millipore Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 77. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 78. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 79. Hologic Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 80. Immunetics Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 81. InBios International Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 82. Life Technologies Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 83. Maxim Biomedical Revenue Growth Rate in Infectious Disease Testing Business (2018-2023)
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network